Nippon Life Insurance Co, the largest Japanese life insurer by revenue, announced that it has decided to invest about $100 million in Life Science Impact Program, a healthcare impact fund managed by the affiliates of private equity and venture capital investor Grove Street Advisors (GroveStreet).
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
